Health Canada just approved elinzanetant, a breakthrough drug specifically for breast cancer patients suffering from severe hot flashes and night sweats — symptoms that often force treatment interruptions and wreck quality of life. Unlike traditional hormone therapy, this drug targets nerve signals disrupted by low estrogen, offering a safe, evidence-based solution for women on anti-estrogen meds or chemo. Clinical trials showed dramatic symptom relief and improved sleep, with most patients eager to keep taking it despite mild side effects. This approval marks a major leap forward in supportive cancer care, giving patients the tools to stay on track with treatment and reclaim their well-being.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
